10x Genomics Files 8-K with Financial Updates
Ticker: TXG · Form: 8-K · Filed: May 8, 2025 · CIK: 1770787
| Field | Detail |
|---|---|
| Company | 10x Genomics, Inc. (TXG) |
| Form Type | 8-K |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations, exit-costs
Related Tickers: TXG
TL;DR
10x Genomics dropped an 8-K on May 6th covering financials and exit costs. Check it out.
AI Summary
On May 6, 2025, 10x Genomics, Inc. filed an 8-K report detailing significant financial and operational updates. The filing includes information on the company's results of operations and financial condition, as well as costs associated with exit or disposal activities. It also contains financial statements and exhibits.
Why It Matters
This 8-K filing provides investors with crucial, up-to-date information on 10x Genomics' financial performance and any restructuring or exit-related costs, impacting their investment decisions.
Risk Assessment
Risk Level: medium — The filing contains financial information and details on exit costs, which can indicate potential restructuring or challenges within the company.
Key Players & Entities
- 10x Genomics, Inc. (company) — Registrant
- May 6, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-39035 (identifier) — SEC File Number
- 45-5614458 (identifier) — IRS Employer Identification No.
- 6230 Stoneridge Mall Road, Pleasanton, California 94588 (address) — Registrant's principal executive offices
- (925) 401-7300 (phone_number) — Registrant's principal executive offices phone number
FAQ
What specific financial results are being reported in this 8-K?
The filing indicates it covers 'Results of Operations and Financial Condition' but does not provide specific figures within the provided text.
What are the 'Cost Associated with Exit or Disposal Activities' mentioned?
The filing states these costs are part of the report, but the specific nature and amount of these costs are not detailed in the provided text.
When was the earliest event reported in this filing?
The earliest event reported was on May 6, 2025.
What is the principal business address of 10x Genomics, Inc.?
The principal business address is 6230 Stoneridge Mall Road, Pleasanton, California 94588.
What is the SEC file number for 10x Genomics, Inc.?
The SEC file number is 001-39035.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding 10x Genomics, Inc. (TXG).